Fructosamine measurement for diabetes mellitus diagnosis and monitoring: A systematic review and meta-analysis protocol

BMJ Open

Volumn 5, Issue 5, 2015, Pages

  Nansseu, Jobert Richie N ^a,b   Fokom Domgue, Joël ^b   Noubiap, Jean Jacques N ^c   Balti, Eric V ^d,e,f   Sobngwi, Eugène ^b,d   Kengne, André Pascal ^g  

^a Department of Paediatrics   (Cameroon)

^b UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d YAOUNDÉ CENTRAL HOSPITAL   (Cameroon)

^e VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^f UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^g UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FRUCTOSAMINE; GLUCOSE; HEMOGLOBIN A1C; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

BLOOD GLUCOSE MONITORING; CLINICAL EVALUATION; CONTROLLED CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FRUCTOSAMINE BLOOD LEVEL; HUMAN; INFORMATION RETRIEVAL; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY DIAGNOSIS; MEASUREMENT; MEASUREMENT ACCURACY; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREDICTIVE VALUE; PREGNANCY DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TIME SERIES ANALYSIS; ANALYSIS; BAYES THEOREM; BLOOD; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST;

BAYES THEOREM; BIOMARKERS; BLOOD GLUCOSE; DIABETES MELLITUS; FRUCTOSAMINE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 84930205497     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-007689     Document Type: Review

References (30)

1. International Diabetes Federation (IDF). Diabetes atlas. 6th edn. Brussels: International Diabetes Federation, 2013.
2. The Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
4. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. J Am Coll Cardiol 2004;44:720-32.
5. Day JF, Ingebretsen CG, Ingebretsen WR, et al. Non-enzymatic glycosylation of serum proteins and hemoglobin: response to changes in blood glucose levels in diabetic rats. Diabetes 1980;29:524-7.
6. Nagasaka Y, Fujii S, Yaga K, et al. Clinical application of measuring serum fructosamine as an index of glycemic control in diabetic patients. Bull Yamaguchi Med Sch 1988;35:59-62.
7. Baker J, Reid I, Holdaway I. Serum fructosamine in patients with diabetes mellitus. N Z Med J 1985;98:532-5.
8. Hindle EJ, Rostron GM, Clark SA, et al. Serum fructosamine and glycated haemoglobin measurements in diabetic control. Arch Dis Child 1986;61:113-17.
9. Dafallah AA, Eskandarani H, Rehaimi A, et al. Fructosamine in HbS and G6PD-deficient Saudi Arabs in the Eastern Province of Saudi Arabia. Br J Biomed Sci 1994;51:332-5.
10. Koga M, Hashimoto K, Murai J, et al. Usefulness of glycated albumin as an indicator of glycemic control status in patients with hemolytic anemia. Clin Chim Acta 2011;412:253-7.
11. Hughes PF, Agarwal M, Newman P, et al. An evaluation of fructosamine in screening for gestational diabetes mellitus. Diabet Med 1995;12:708-12.
12. Agarwal MM, Hughes PF, Punnose J, et al. Gestationaldiabetes screening of a multi-ethnic, high risk population using glycated proteins. Diabetes Res Clin Pract 2001;51:67-73.
13. Islam N, Akhter J, Kayani N, et al. Fructosamine: an alternative assessment of past glycaemic control in developing countries. J Pak Med Assoc 1993;43:238-40.
14. World Health Organization. Sickle-cell anaemia: report by the secretariat. Geneva: World Health Organization.
15. Aliyu ZY, Gordeuk V, Sachdev V, et al. Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria. Am J Hematol 2008;83:485-90.
16. Misciagna G, Logroscino G, De Michele G, et al. Fructosamine, glycated hemoglobin, and dietary carbohydrates. Clin Chim Acta 2004;340:139-47.
17. Rendell M, Paulsen R, Eastberg S. Clinicaluse and time relationship of changes in affinity measurement of glycosylated albumin and glycosylated hemoglobin. Am J Med Sci 1986;292:11-14.
18. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264-9.
19. Welch V, Petticrew M, Tugwell P, et al. PRISMA-Equity 2012 Extension: reporting guidelines for systematic review with a focus on health equity. PLoS Med 2012;9:e1001333.
20. Higgins JP, Green S, eds. Cochrane handbook for systematic reviews of interventions. Versions 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.
21. Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011;155:529-36.
22. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58.
23. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
24. Reitsma JB, Glas AS, Rutjes AW, et al. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 2005;58:982-90.
25. Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 2001;20:2865-84.
26. Harbord RM, Deeks JJ, Egger M, et al. A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics 2007;8:239-51.
27. Gasparrini A, Armstrong B, Kenward MG. Multivariate meta-analysis for non-linear and other multi-parameter associations. Stat Med 2012;31:3821-39.
28. Doebler P, Holling H, Böhning D. A mixed model approach to meta-analysis of diagnostic studies with binary test outcome. Psychol Methods 2012;17:418-36.
29. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000;56:455-63.
30. Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4:1.